The presentation of contralateral axillary lymph node metastases from breast carcinoma: A clinical management dilemma

Breast Journal

Volumn 13, Issue 2, 2007, Pages 158-164

  Huston, Tara L ^a   Pressman, Peter I ^a   Moore, Anne ^a   Vahdat, Linda ^a   Hoda, Syed A ^a   Kato, Meredith ^a   Weinstein, Douglas ^a   Tousimis, Eleni ^a,b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Axillary recurrence; Breast cancer; Contralateral axillary lymph node metastases; Lymphatic drainage; Staging

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE; HORMONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER HORMONE THERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CAUSE OF DEATH; CLINICAL ARTICLE; DEMOGRAPHY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHADENECTOMY; PROTEIN EXPRESSION; SYSTEMIC DISEASE;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN;

EID: 33847165765     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00390.x     Document Type: Article

References (14)

1. Daoud J, Meziou M, Kharrat M, et al. [Contralateral axillary lymph node metastasis of cancer of the breast]. Bull Cancer 1998;85:713-15.
2. Vlastos G, Jean ME, Mirza AN, et al. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 2001;8:425-31.
3. Hainsworth JD, Greco FA. Treatment of patients with cancer of an unknown primary site. NEJM 1993;329:257-63.
4. Rosen PP. Axillary lymph node metastases in patients with occult noninvasive breast carcinoma. Cancer 1980;46:1298-306.
5. Harms SE, Rabinovitch R, Julian TB, Rafferty E, Masood S, Weatherall P. Report of the working groups on breast MRI: report of the breast cancer staging group. Breast J 2004;10:S3-S8.
6. Rosen PP, Kimmel M. Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients. Hum Pathol 1990;21:518-23.
7. Blanchard DK, Farley DR. Retrospective study of women presenting with axillary metastases from occult breast carcinoma. World J Surg 2004;28:535-39.
8. Matsuoka K, Ohsumi S, Takashima S, Saeki T, Aogi K, Mandai K. Occult breast carcinoma presenting with axillary lymph node metastases: follow-up of eleven patients. Breast Cancer 2003;10:330-34.
9. Sappey MPC. Injection preparation et conservation des vaisseaux lymphatiques. These pour le doctorat en medicine, no 241. Paris: Rignoux Imprimeur de la Faculte de Medecine, 1834.
10. Turner-Warwick RT. The lymphatics of the breast. Br J Surg 1959;46:574-82.
11. Haagensen CD, Feind KR, Herter FP, Slanetz CA, Weinberg JA. The lymphatics in cancer. Philadelphia, PA: WB Saunders Company, 1972.
12. Eroglu A, Mudun A, Berberoglu K, et al. Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. Clin Nucl Med 2004;29:306-11.
13. Perre CI, Hoefnagel CA, Kroon BB, Zoetmulder FA, Rutgers EJ. Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with breast cancer. Br J Surg 1996;83:1258.
14. Devitt JE, Michalchuk AW. Significance of contralateral axillary metastases in carcinoma of the breast. Can J Surg 1969;12:178-80.